相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients
Meijiao Zhou et al.
CLINICAL COLORECTAL CANCER (2022)
Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study
Jemma M. Boyle et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose
Michael Webster-Clark et al.
JAMA ONCOLOGY (2022)
Morbidity and mortality following major large bowel resection for colorectal cancer detected by a population-based screening program
Lawrence F. Paszat et al.
JOURNAL OF MEDICAL SCREENING (2021)
Missing Data in Clinical Research: A Tutorial on Multiple Imputation
Peter C. Austin et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
Devon J. Boyne et al.
JAMA NETWORK OPEN (2021)
Noncollapsibility, confounding, and sparse-data bias. Part 2: What should researchers make of persistent controversies about the odds ratio?
Sander Greenland
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis
Julie Hallet et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Overlap Weighting A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial
Laine E. Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma
Michael J. Raphael et al.
JAMA ONCOLOGY (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
Thierry André et al.
LANCET ONCOLOGY (2020)
Propensity score analysis with partially observed covariates: How should multiple imputation be used?
Clemence Leyrat et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
The association of continuity of care and cancer centre affiliation with outcomes among patients with cancer who require emergency department care
Keerat Grewal et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline
Christopher Lieu et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
New Guidelines for Statistical Reporting in the Journal
David Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A comparison of different methods to handle missing data in the context of propensity score analysis
Jungyeon Choi et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)
Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer A Systematic Review and Meta-analysis
Devon J. Boyne et al.
JAMA NETWORK OPEN (2019)
Balancing Covariates via Propensity Score Weighting
Fan Li et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2018)
A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab
Nancy N. Baxter et al.
DISEASES OF THE COLON & RECTUM (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Can Chemotherapy-Related Acute Care Visits Be Accurately Identified in Administrative Data?
Monika K. Krzyzanowska et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer
Safiya Karim et al.
JAMA ONCOLOGY (2017)
Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population
C. M. Booth et al.
CLINICAL ONCOLOGY (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
Eric I. Benchimol et al.
PLOS MEDICINE (2015)
Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer
David W. Wasserman et al.
JOURNAL OF ONCOLOGY PRACTICE (2015)
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
D. Papamichael et al.
ANNALS OF ONCOLOGY (2015)
The Mortality Risk Score and the ADG Score Two Points-Based Scoring Systems for the Johns Hopkins Aggregated Diagnosis Groups to Predict Mortality in a General Adult Population Cohort in Ontario, Canada
Peter C. Austin et al.
MEDICAL CARE (2011)
Impact of Smoking on Patients With Stage III Colon Cancer Results From Cancer and Leukemia Group B 89803
Nadine Jackson McCleary et al.
CANCER (2010)
Imputing missing covariate values for the Cox model
Ian R. White et al.
STATISTICS IN MEDICINE (2009)
Frailty: An emerging research and clinical paradigm - Issues and controversies
Howard Bergman et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Model selection, confounder control, and marginal structural models: Review and new applications
MM Joffe et al.
AMERICAN STATISTICIAN (2004)
分享论文
